INTERNATIONAL PATENT: DAEWOONG PHARMACEUTICAL CO., LTD. FILES APPLICATION FOR "NOVEL HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS DNA POLYMERASE THETA INHIBITORS FOR THE PREVENTION OR TREATMENT OF CANCER"

GENEVA, Aug. 12 -- DAEWOONG PHARMACEUTICAL CO., LTD. (35-14, Jeyakgongdan 4-gil, Hyangnam-eup,Hwaseong-si,Gyeonggi-do 18623) filed a patent application (PCT/KR2025/001405) for "NOVEL HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS DNA POLYMERASE THETA INHIBITORS FOR THE PREVENTION OR TREATMENT OF CANCER" on Jan 24, 2025. With publication no. WO/2025/165092, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CAO, Bin (Building 2-1, No. 215, Simbay Park, South Fute Road, Waigaoqiao Free Trade Zone,...